Literature DB >> 23763641

Histopathological evaluation of resected colorectal cancer liver metastases: what should be done?

Nikki Knijn1, Jannemarie A M de Ridder, Cornelis J A Punt, Johannes H W de Wilt, Iris D Nagtegaal.   

Abstract

Histological reporting of hepatic resections of colorectal liver metastases (CRLMs) is limited to confirmation of diagnosis and evaluation of resection margins. More exhaustive diagnostic reporting might be warranted. Here, we critically and systematically review the potentially important histological prognostic factors in CRLM. Histological features such as intrahepatic spread, resection margins, and tumour response to neoadjuvant chemotherapy have been defined. Intrahepatic spread (venous, lymphatic, bile duct and perineural invasion) was evaluated in a number of studies. Meta-analysis demonstrated a clear correlation between 5-year overall survival and both portal vein invasion (RR 1.8, 95% CI 1.3-2.5) and lymphatic invasion (RR 1.7, 95% CI 1.4-2.0). The impact of hepatic vein invasion and bile duct invasion on outcome is not clear. Perineural invasion was linked to survival in one study. Resection margin is an important prognostic factor; however, the significance of the width of negative margins remains controversial. Various studies have evaluated tumour response to neoadjuvant chemotherapy, but different grading systems were used, and definite recommendations cannot be made. In conclusion, with the high incidence of CRLM and the increase in the number of hepatic resections, we need well-defined prognostic factors, studied in homogeneous patient populations, to optimize diagnostic work-up. This review identifies several of these factors.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  colorectal cancer; hepatic resection; histology; liver metastases; prognostic factor

Mesh:

Year:  2013        PMID: 23763641     DOI: 10.1111/his.12124

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  15 in total

Review 1.  Pathologic assessment of gastrointestinal tract and pancreatic carcinoma after neoadjuvant therapy.

Authors:  Reetesh K Pai; Rish K Pai
Journal:  Mod Pathol       Date:  2017-08-04       Impact factor: 7.842

2.  Growth pattern of colorectal liver metastasis as a marker of recurrence risk.

Authors:  R L Eefsen; P B Vermeulen; I J Christensen; O D Laerum; M B Mogensen; H C Rolff; G G Van den Eynden; G Høyer-Hansen; K Osterlind; B Vainer; M Illemann
Journal:  Clin Exp Metastasis       Date:  2015-03-31       Impact factor: 5.150

Review 3.  [New aspects for staging and grading of tumor metastases].

Authors:  C Wittekind
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

4.  Critical review of the prognostic significance of pathological variables in patients undergoing resection for colorectal liver metastases.

Authors:  Dhanwant Gomez; Abed M Zaitoun; Antonella De Rosa; Sina Hossaini; Ian J Beckingham; Adam Brooks; Iain C Cameron
Journal:  HPB (Oxford)       Date:  2014-03-12       Impact factor: 3.647

Review 5.  Surgery for colorectal liver metastases: The evolution of determining prognosis.

Authors:  Gaya Spolverato; Aslam Ejaz; Nilo Azad; Timothy M Pawlik
Journal:  World J Gastrointest Oncol       Date:  2013-12-15

6.  Pathologic assessment of response to chemotherapy in colorectal cancer liver metastases after hepatic resection: which method to use?

Authors:  K Dede; F Salamon; L Landherr; F Jakab; A Bursics
Journal:  Pathol Oncol Res       Date:  2014-06-05       Impact factor: 3.201

7.  Histopathological prognostic factors for colorectal liver metastases: A systematic review and meta-analysis of observational studies.

Authors:  Cássio Virgílio Cavalcante de Oliveira; Gilton Marques Fonseca; Jaime Arthur Pirola Kruger; Evandro Sobroza de Mello; Fabricio Ferreira Coelho; Paulo Herman
Journal:  Histol Histopathol       Date:  2020-11-09       Impact factor: 2.303

8.  Lymphatic Invasion is an Independent Adverse Prognostic Factor in Patients with Colorectal Liver Metastasis.

Authors:  Jannemarie A M de Ridder; Nikki Knijn; Bastiaan Wiering; Johannes H W de Wilt; Iris D Nagtegaal
Journal:  Ann Surg Oncol       Date:  2015-05-19       Impact factor: 5.344

9.  MicroRNA 141 Expression Is a Potential Prognostic Marker of Biliary Tract Cancers.

Authors:  Jaihwan Kim; Ji Kon Ryu; Sang Hyub Lee; Yong-Tae Kim
Journal:  Gut Liver       Date:  2016-09-15       Impact factor: 4.519

10.  Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in Colorectal Liver Metastases (CRLM): Looking Beyond the Tumor Margin.

Authors:  Pulathis N Siriwardana; Tu Vinh Luong; Jennifer Watkins; Helen Turley; Mohamed Ghazaley; Kevin Gatter; Adrian L Harris; Daniel Hochhauser; Brian R Davidson
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.